Pathogenic mechanisms of congenital heart disease

Fetal and Pediatric Pathology

Volumn 29, Issue 5, 2010, Pages 359-372

  Huang, Jing Bin ^a   Liu, Ying Long ^a   Lv, Xiao Dong ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Cardiac development; Congenital heart disease; Molecular mechanisms

Indexed keywords

CONGENITAL HEART DISEASE; GENETIC DISORDER; HEART DEVELOPMENT; HUMAN; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; EPIGENESIS, GENETIC; HEART; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; MICRORNAS; ORGANOGENESIS;

EID: 77955646966     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.3109/15513811003789628     Document Type: Review

References (68)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 39:1890-1900, 2002.
2. Garg V. Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci 63(10):1141-1148, 2006.
3. Kohl HW III. Rubella screening and vaccination follow-up by a hospital employee health office. Am J Infect Control 13(3):124-127, 1985.
4. Singh M, Shah GL, Singh KP. Teratogenic effects of dilantin on thoraco-abdominal organs of developing chick embryos. Indian J Exp Biol 38(10):1026-1030, 2000.
5. Dawson BV, Johnson PD, Goldberg SJ, Ulreich JB. Cardiac teratogenesis of halogenated hydrocarbon-contaminated drinking water. J Am Coll Cardiol 21(6):1466-1472, 1993.
6. Kumar SD, Dheen ST, Tay SS. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol 6:34, 2007.
7. Moorman AF, Christoffels S. Cardiac chamber formation: Development, genes, and evolution. Physiol Rev 83(4):1223-1267, 2003.
8. Mitchell ME, Sander TL, Klinkner DB, et al. The molecular basis of congenital heart disease. Semin Thorac Cardiovasc Surg 19(3):228-237, 2007.
9. Dunwoodie SL. Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation. Semin Cell Dev Biol 18(1):54-66, 2007.
10. Brand T. Heart development: molecular insights into cardiac specification and early morphogenesis. Developmental Biology 258(1):1-19, 2003.
11. Gruber PJ, Epstein JA. Development gone awry congenital heart disease. Circ Res 94(3):273-283, 2004.
12. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science 313(5795):1922-1927, 2006.
13. Grego-Bessa J, Luna-Zurita L, del Monte G, Bolós V, Melgar P, Arandilla A, Garratt AN, Zang H, Mukouyama YS, Chen H, Shou W, Ballestar E, Esteller M, Rojas A, Pérez-Pomares JM, De La Pompa JL. Notch signaling is essential for ventricular chamber development. Dev Cell 12(3):415-429, 2007.
14. Risebro CA, Riley PR. Formation of the ventricles. Scientific World J 6:1862-1880, 2006.
15. Cohen ED, Tian Y, Morrisey EE. Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135(5):789-798, 2008.
16. Xiao H, Zhang YY. Understanding the role of transforming growth factor-beta signaling in the heart: overview of studies using genetic mouse models. Clin Exp Pharmacol Physiol 35(3):335-341, 2008.
17. Moon JI, Birren SJ. Target-dependent inhibition of sympathetic neuron growth via modulation of a BMP signaling pathway. Dev Biol 315(2):404-417, 2008.
18. Mjaatvedt CH., Nakaoka T, Moreno-Rodriguez R, Norris RA, Kern MJ, Eisenberg CA et al. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol 238(1):97-109, 2001.
19. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science. 313(5795):1922-1927, 2006.
20. Wagner M, Siddiqui MA. Signal transduction in early heart development (II): Ventricular chamber specification, trabeculation, and heart valve formation. Exp Biol Med (Maywood) 232(7):866-880, 2007. (Pubitemid 47026792)
21. Armstrong EJ, Bischoff J. Heart valve development: Endothelial cell signaling and differentiation. Circ Res 95(5):459-470, 2004.
22. Yutzey KE, Colbert M, Robbins J. Ras-related signaling pathways in valve development: Ebb and flow. Physiology (Bethesda) 20:390-397, 2005.
23. Joziasse IC, van de Smagt JJ, Smith K, Bakkers J, Sieswerda GJ, Mulder BJ, Doevendans PA. Genes in congenital heart disease: atrioventricular valve formation. Basic Res Cardiol 103(3):216-227, 2008.
24. Hamada H, Meno C, Watanabe D, Saijoh Y. Establishment of vertebrate left-right asymmetry. Nat Rev Genet 3:103-113, 2002.
25. Capdevila J, Vogan KJ, Tabin CJ, Izpisua Belmonte JC. Mechanisms of left-right determination in vertebrates. Cell 101(1):9-21, 2000.
26. Yue Q, Wagstaff L, Yang X, Weijer C, Münsterberg A. Wnt3a-mediated chemo-repulsion controls movement patterns of cardiac progenitors and requires RhoA function. Development 135(6):1029-1037, 2008.
27. High FA, Epstein JA.The multifaceted role of Notch in cardiac development and disease. Nat Rev Genet 9(1):49-61, 2008.
28. Ikeda Y, Hiroi Y, Hosoda T, Utsunomiya T, Matsuo S, Ito T, Inoue J, Sumiyoshi T, Takano H, Nagai R, Komuro I. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circ J 66:561-563, 2002.
29. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42:1650-1655, 2003.
30. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, Taylor P, Grossfeld P, Fatkin D, Jones O, Hayes P, Feneley M, Harvey RP. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol 41:2072-2076, 2003.
31. Schubbert S, Zenker M, Rowe SL, Boll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, Nguyen H, West B, Zhang KY, Sistermans E, Rauch A, Niemeyer CM, Shannon K, Kratz CP. Germline KRAS mutations cause Noonan syndrome. Nat Genet 38:331-336, 2006.
32. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563, 2002.
33. Pierpont ME, Basson CT, Benson Jr DW, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL. Genetic basis for congenital heart defects. Current knowledge: A scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young. Endorsed by the American Academy of Pediatrics. Circulation 115(23):3015-3038, 2007.
34. Bittel DC, Kibiryeva N, O'Brien JE, Lofland GK, Butler MG. Gene expression in pediatric heart disease with emphasis on conotruncal defects. Progress in Pediatric Cardiology 20(1):127-141, 2005.
35. Bruneau BG. The developmental genetics of congenital heart disease. Nature 451(7181):943-948, 2008.
36. Hyun C, Lavulo L. Congenital heart diseases in small animals: Part I. Genetic pathways and potential candidate genes. The Veterinary Journal 171(2):245-255, 2006. (Pubitemid 43257228)
37. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat. Genet 28(3): 276-280, 2001.
38. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 104(21): 2565-2568, 2001.
39. Stennard FA, Costa MW, Elliott DA, Rankin S, Haast SJ, Lai D, McDonald LP, Niederreither K, Dolle P, Bruneau BG, Zorn AM, Harvey RP. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 262(2):206-224, 2003.
40. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S., et al. Nkx2-5 pathways and congenital heart disease: loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117(3):373-386, 2004.
41. Pu WT, Ishiwata T, Juraszek AL, Ma Q, Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 275(1):235-244, 2004.
42. Moskowitz IP, Kim JB, Moore ML, Wolf CM, Peterson MA, Shendure J, Nobrega MA, Yokota Y, Berul C, Izumo S, Seidman JG, Seidman CE. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129(7):1365-1376, 2007.
43. Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 37(4): 423-428, 2005.
44. VaradkarP,KramanM,DespresD,MaG, LozierJ,McCrightB. Notch2 isrequired for the proliferation of cardiac neural crest-derived smooth muscle cells. Dev Dyn. 237(4):1144-1152, 2008.
45. Del Monte G, Grego-Bessa J, González-Rajal A, Bolós V, De La Pompa JL. Monitoring Notch1 activity in development: evidence for a feedback regulatory loop. Dev Dyn. 236(9):2594-2614, 2007.
46. Kwon C, Arnold J, Hsiao EC, Taketo MM, Conklin BR, Srivastava D. Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci USA;104(26):10894-10899, 2007.
47. Miller CT, Swartz ME, Khuu PA, Walker MB, Eberhart JK, Kimmel CB. mef2ca is required in cranial neural crest to effect Endothelin 1 signaling in zebrafish. Dev Biol 308(1):144-157, 2007.
48. Ren X, Li Y, Ma X, Zheng L, Xu Y, Wang J. Activation of p38/MEF2C pathway by all-trans retinoic acid in cardiac myoblasts. Life Sci 81(2):89-96, 2007. (Pubitemid 46921175)
49. Ueno S, Weidinger G, Osugi T, Kohn AD, Golob JL, Pabon L, Reinecke H, Moon RT, Murry CE. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci\USA 104(23):9685-9690, 2007.
50. Groenendijk BC, Stekelenburg-de Vos S, Vennemann P, Wladimiroff JW, Nieuwstadt FT, Lindken R, Westerweel J, Hierck BP, Ursem NT, Poelmann RE. The endothelin-1 pathway and the development of cardiovascular defectsinthe haemodynamically challenged chicken embryo. J Vasc Re;45(1):54-68, 2008.
51. Couzin J. Breakthrough of the year: Small RNAs make big splash. Science 298(5602): 2296-2297, 2002.
52. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci\USA.101(26):9740-9744, 2004.
53. Lee CT, Risom T, Strauss WM. MicroRNAs in mammalian development. Birth Defects Res C Embryo Today 78(2):129-139, 2006.
54. Zhang B, Wang Q, Pan X. MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210(2): 279-289, 2007.
55. Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129(2):303-317, 2007.
56. Zhao Y, Samal E, Srivastava D. Serum sponse factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 36(7048):214-220, 2005.
57. Kwon C, Han Z, Olson EN, et al. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci USA 102(52): 18986-18991, 2005.
58. Albert HC, Wong II. Gottesman,Arturas Petronis. Phenotypic differences in genetically identical organisms: the epigenetic perspective. Human Molecular Genetics 14(1):R11-R18, 2005.
59. Armstrong L, Lako M, Dean W, Stojkovic M. Epigenetic modification is central to genome repro-gramming in somatic cell nuclear transfer. Stem Cells 24(4):805-814, 2006.
60. Jacinto FV: Esteller M. Mutator pathways unleashed by epigenetic silencing in human cancer. Muta-genesi 22(4):247-253, 2007.
61. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158-173, 2007.
62. Cambien F, Tiret L. Genetics of cardiovascular diseases: From single mutations to the whole genome. Circulation 116:1714-1724, 2007.
63. Gatzoulis MA. Adult congenital heart disease: a cardiovascular area of growth in urgent need of additional resource allocation. Int J Cardiol 97 (suppl 1):1-2, 2004.
64. Warnes CA, The adult with congenital heart disease, born to be bad? JACC 46(1):1-8, 2005.
65. Cohen JC. Genetic approaches to coronary heart disease. JACC 48(9)suppl A 7:A10-4, 2006.
66. Wallace C, Newhouse SJ, Braund P, et al. Genome-wide association study identifies genes for biomark-ers of cardiovascular disease: Serum urate and dyslipidemia. The American Journal of Human Genetics 82:139-149, 2008.
67. Todd AK. Bioinformatics approaches to quadruplex sequence location. Methods 43(4):246-251, 2007.
68. Yang W, Paschen W. Conditional gene silencing in mammalian cells mediated by a stress-inducible promoter. Biochemical and Biophysical Research Communications 365(3):521-527, 2008.